2. Beijing Sihuan Bio-Pharmaceutical Co., Ltd. was established in 1988 with stock code 005 18, referred to as "Sihuan Bio" for short. China is the earliest high-tech enterprise engaged in the research, pilot test, production and sales of genetic engineering drugs and diagnostic reagents, integrating science, industry and trade, and it is also one of the earliest industrialization bases of genetic engineering drugs in China.
3. China Pharmaceutical Group Co., Ltd. is a medical and health industry group with the largest scale, the most complete industrial chain and the strongest comprehensive strength in China directly managed by the State-owned Assets Supervision and Administration Commission of the State Council. It focuses on distribution, retail, research and development and production of health-related products, such as preventive treatment and diagnostic care. It owns a wholly-owned or holding subsidiary of 1 1, and five listed companies, including Sinopharm Holdings, Sinopharm Holdings, Tiantan Bio, Hyundai Pharmaceutical and Consistent Pharmaceutical. From 2003 to 20 1 1 year, the average annual growth rates of the group's operating income, total profit and total assets were 33%, 44% and 35% respectively. In 20 12 years, the operating income exceeded16 billion yuan, and it is the only medical and health industry group in China that exceeds 100 billion yuan.
4. Jiangsu Lianhuan Pharmaceutical Co., Ltd. is a joint-stock pharmaceutical enterprise that produces and sells chemical raw materials, chemical pharmaceutical preparations and organic intermediates. On March 4th, 2003, with the approval of China Securities Regulatory Commission, 20 million A shares were publicly issued on the Shanghai Stock Exchange and successfully listed on March 19. The stock is called Lianhuan Pharmaceutical for short and the stock code is 6005 13.
5.1959,65438+10, Wohua Medicine established Shandong Weifang Chinese Medicine Factory on the basis of the Chinese Medicine Processing Department of Wanhetang Yaozhuang and the Piece Processing Group of Shandong Changwei Central Medicine Company. In February 2002, it was restructured into Weifang Wohua Pharmaceutical Technology Co., Ltd. ... On June 24, 2007, the company's shares were officially listed in Shenzhen Stock Exchange, becoming the first listed pharmaceutical enterprise in Weifang. On August 8, 2008, the private placement of shares of Wohua Pharmaceutical was successful.